Clinical trial
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
NCT00212628 · Ono Pharmaceutical Co. Ltd, Industry · Completed
Key facts
| NCT number | NCT00212628 |
|---|---|
| Title | Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan |
| Official title | Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan |
| Lead sponsor | Ono Pharmaceutical Co. Ltd, Industry |
| Collaborators | Astellas Pharma Inc Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Involutional Osteoporosis |
| Intervention type | Drug |
| Interventions | Minodronic acid hydrate |
| Enrollment | 444 |
| Start date | Jun 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 14, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: